CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-154535 | Pharmaceuticals and Healthcare
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Contract Bio-manufacturing Organization (CMO) Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET
7.1 GLOBAL CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA CONTRACT BIO-MANUFACTURING ORGANIZATION (CMO) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Abzena
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Althea
16.3 Asymchem Laboratories Inc.
16.4 Baxter Biopharma Solutions
16.5 Biomeva
16.6 Boehringer Ingelheim
16.7 Celltrion
16.8 AGC Biologics
16.9 Cytovance Biologics
16.10 Fujifilm Diosynth Technologies
16.11 KBI Biopharma
16.12 Lonza Group
16.13 MicroProtein Technologies
16.14 Patheon
16.15 Porton Pharma Solutions
16.16 Probiogen
16.17 Rader
16.18 Rentschler Biotechnologie
16.19 Samsung
16.20 Sandoz
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeBig Bio/Pharma Type
Small/Med Bio/Pharma Type
Virtual/Emerging By Type
By Application
Pharmaceutical Industry
Biotechnology
Companies
Abzena
Althea
Asymchem Laboratories Inc.
Baxter Biopharma Solutions
Biomeva
Boehringer Ingelheim
Celltrion
AGC Biologics
Cytovance Biologics
Fujifilm Diosynth Technologies
KBI Biopharma
Lonza Group
MicroProtein Technologies
Patheon
Porton Pharma Solutions
Probiogen
Rader
Rentschler Biotechnologie
Samsung
Sandoz
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.